• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. - CRM FACILITY PARADYM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. - CRM FACILITY PARADYM; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO Back to Search Results
Model Number PARADYM SONR CRT-D 8770
Device Problem Unexpected Therapeutic Results (1631)
Patient Problems Atrial Fibrillation (1729); Tachycardia (2095)
Event Date 10/30/2019
Event Type  malfunction  
Manufacturer Narrative
The device model involved in this mdr report is not approved in the united states; however, it is similar to a device manufactured by sorin that was cleared or approved by fda for marketing in the united states.
 
Event Description
Reportedly, on (b)(6) 2019, the patient was hospitalized due to suspicious of previously untreated ventricular tachycardias (vt).The device was interrogated and 12 episodes were found; only one dated (b)(6) 2019 was classified as vt with a therapy delivered.The episodes dated (b)(6) 2019 were classified as supraventricular tachycardia (svt); consequently, no therapy was delivered.No ventricular undersensing was observed and the device was programmed in parad+ (stability+/acceleration) despite an atrial fibrillation was occurring in the same time.Preliminary analysis revealed that the device behaved within specifications and according to the programmed parameters.
 
Event Description
Reportedly, on (b)(6) 2019, the patient was hospitalized due to suspicious of previously untreated ventricular tachycardias (vt).The device was interrogated and 12 episodes were found; only one dated (b)(6) 2019 was classified as vt with a therapy delivered.The episodes dated (b)(6) 2019 were classified as supraventricular tachycardia (svt); consequently, no therapy was delivered.No ventricular undersensing was observed and the device was programmed in parad+ despite an atrial fibrillation was occurring in the same time.The device was reprogrammed in stability+/acceleration on (b)(6) 2019.Preliminary analysis revealed that the device behaved within specifications and according to the programmed parameters.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARADYM
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CARDIAC RESYNCHRONIZATIO
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
parc d'affaires noveos 4 avenue réaumur
.
clamart 92140
FR  92140
MDR Report Key9384471
MDR Text Key177201868
Report Number1000165971-2019-00654
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 02/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/19/2015
Device Model NumberPARADYM SONR CRT-D 8770
Device Catalogue NumberPARADYM SONR CRT-D 8770
Device Lot Number2802
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Distributor Facility Aware Date11/04/2019
Initial Date Manufacturer Received 11/04/2019
Initial Date FDA Received11/27/2019
Supplement Dates Manufacturer Received01/28/2020
Supplement Dates FDA Received02/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-